Robert Kramer

Insider Reports History

Location
Rockville, MD
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Kramer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Emergent BioSolutions Inc. President and CEO, Director Common Stock 506,059 $921,027 $1.82 09 Jun 2023 Direct
Emergent BioSolutions Inc. President and CEO, Director Employee Stock Option (Right to buy) 535,051 09 Jun 2023 Direct
Emergent BioSolutions Inc. President and CEO, Director Employee Stock Options (Right to Buy) 258,182 02 Mar 2023 Direct

Insider Reports Filed by Robert Kramer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EBS Emergent BioSolutions Inc. 09 Jun 2023 3 $0 4 President and CEO, Director 13 Jun 2023, 21:20
EBS Emergent BioSolutions Inc. 02 Mar 2023 3 $0 4 President and CEO, Director 06 Mar 2023, 18:37
EBS Emergent BioSolutions Inc. 28 Feb 2023 1 -$39,938 4 President and CEO, Director 02 Mar 2023, 13:42
EBS Emergent BioSolutions Inc. 23 Feb 2023 2 -$42,233 4 President and CEO, Director 27 Feb 2023, 19:22
EBS Emergent BioSolutions Inc. 08 Feb 2023 2 -$65,508 4 President and CEO, Director 10 Feb 2023, 19:36
EBS Emergent BioSolutions Inc. 28 Feb 2022 4 +$5,531,973 4 President and CEO, Director 02 Mar 2022, 18:25
EBS Emergent BioSolutions Inc. 23 Feb 2022 2 -$146,308 4 President and CEO, Director 25 Feb 2022, 16:18
EBS Emergent BioSolutions Inc. 22 Feb 2022 2 -$194,047 4 President and CEO, Director 24 Feb 2022, 17:56
EBS Emergent BioSolutions Inc. 08 May 2021 1 -$5,792 4 President and CEO, Director 11 May 2021, 16:25